Business
AstraZeneca Shares Drop, Bristol Myers Squibb’s Climb After Merger Talks Reports
shares fell sharply and Bristol Myers Squibb’s BMY 1.13%increase; up pointing triangle climbed, after media reports that the two drugmakers held merger talks.
London-listed shares in AstraZeneca were down 6.4% in European morning trading. Meanwhile, Bristol’s shares were up 5.5% in U.S. premarket trading.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
You must be logged in to post a comment Login